Comparison of Nasopharyngeal MR, 18 F-FDG PET/CT, and 18 F-FDG PET/MR for Local Detection of Natural Killer/T-Cell Lymphoma, Nasal Type

被引:5
|
作者
Guo, Rui [1 ]
Xu, Pengpeng [2 ]
Cheng, Shu [2 ]
Lin, Mu [3 ]
Zhong, Huijuan [2 ]
Li, Weixia [4 ]
Huang, Hengye [5 ]
Ouyang, Bingsheng [6 ]
Yi, Hongmei [6 ]
Chen, Jiayi [7 ]
Lin, Xiaozhu [1 ]
Shi, Kuangyu [8 ,9 ]
Zhao, Weili [2 ]
Li, Biao [1 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Nucl Med, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, State Key Lab Med Genom, Shanghai, Peoples R China
[3] Siemens Healthcare, Beijing, Peoples R China
[4] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Radiol, Shanghai, Peoples R China
[5] Shanghai Jiao Tong Univ, Sch Publ Hlth, Shanghai, Peoples R China
[6] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Pathol, Shanghai, Peoples R China
[7] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Radiat, Shanghai, Peoples R China
[8] Univ Hosp Bern, Dept Nucl Med, Bern, Switzerland
[9] Tech Univ Munich, Fac Informat, Munich, Germany
来源
FRONTIERS IN ONCOLOGY | 2020年 / 10卷
关键词
F-18-FDG; PET; MR; CT; extranodal NK; T-cell lymphoma; nasal-type; EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY; HEALTH-ORGANIZATION CLASSIFICATION; APPARENT DIFFUSION-COEFFICIENT; MATURE T-CELL; CLINICAL-EXPERIENCE; GLUCOSE-METABOLISM; WEIGHTED MRI; UTILITY;
D O I
10.3389/fonc.2020.576409
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives The present study aims to compare the diagnostic efficacy of MR, F-18-FDG PET/CT, and F-18-FDG PET/MR for the local detection of early-stage extranodal natural killer/T-cell lymphoma, nasal type (ENKTL). Patients and Methods Thirty-six patients with histologically proven early-stage ENKTL were enrolled from a phase 2 study (Cohort A). Eight nasopharyngeal anatomical regions from each patient were imaged using F-18-FDG PET/CT and MR. A further nine patients were prospectively enrolled from a multicenter, phase 3 study; these patients underwent F-18-FDG PET/CT and PET/MR after a single F-18-FDG injection (Cohort B). Region-based sensitivity and specificity were calculated. The standardized uptake values (SUV) obtained from PET/CT and PET/MR were compared, and the relationship between the SUV and apparent diffusion coefficients (ADC) of PET/MR were analyzed. Results In Cohort A, of the 288 anatomic regions, 86 demonstrated lymphoma involvement. All lesions were detected by F-18-FDG PET/CT, while only 70 were detected by MR. F-18-FDG PET/CT exhibited a higher sensitivity than MR (100% vs. 81.4%, chi(2) = 17.641, P < 0.001) for local detection of malignancies. The specificity of F-18-FDG PET/CT and MR were 98.5 and 97.5%, respectively (chi(2) = 0.510, P = 0.475). The accuracy of F-18-FDG PET/CT was 99.0% and the accuracy of MR was 92.7% (chi(2) = 14.087, P < 0.001). In Cohort B, 72 anatomical regions were analyzed. PET/CT and PET/MR have a sensitivity of 100% and a specificity of 92.5%. The two methods were consistent (kappa = 0.833, P < 0.001). There was a significant correlation between PET/MR SUVmax and PET/CT SUVmax (r = 0.711, P < 0.001), and SUVmean (r = 0.685, P < 0.001). No correlation was observed between the SUV and the ADC. Conclusion In early-stage ENKTL, nasopharyngeal MR showed a lower sensitivity and a similar specificity when compared with F-18-FDG PET/CT. PET/MR showed similar performance compared with PET/CT.
引用
收藏
页数:10
相关论文
共 50 条
  • [11] 18 F-FDG PET/CT For Staging And Restaging Of Anorectal Melanoma
    Bakare, A. N.
    Agrawal, A.
    Shah, S.
    Purandare, N.
    Puranik, A.
    Rangarajan, V.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S586 - S586
  • [12] Evaluation of breast cancer relapse with (18)F-FDG PET/CT
    Srbovan, D. J.
    Nikoletic, K.
    Mihailovic, J.
    Matovina, E.
    Kozic, D.
    Prvulovic, N.
    Miucin-Vukadinovic, I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S363 - S363
  • [13] Application of 18F-FDG PET/CT in the Diagnosis and Staging of Extranodular Natural Killer/T-cell Lymphoma Nasal Type
    Liu Xiaoting
    Han Xingmin
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [14] Role of 18 F-FDG PET/CT in detection of bone marrow involvement in pediatric Hodgkin lymphoma
    Rahman, Hany Abdel
    Abdallah, Amr
    Ali, Nisserine
    Zaghloul, M. S.
    Omar, Walid
    Taha, Hala
    el Wakeel, Madiha
    Mohamed, Engy
    El Haddad, Alaa
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 182 : 106 - 106
  • [15] Head-to-head comparison of 18 F-FDG PET/CT and 18 F-FDG PET/MRI for lymph node metastasis staging in non-small cell lung cancer: a metaanalysis
    Zhang, Min
    Liu, Zhikang
    Yuan, Yuhang
    Yang, Wenwen
    Cao, Xiong
    Ma, Minjie
    Han, Biao
    DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY, 2024, 30 (02): : 99 - 106
  • [16] Estimation of patient dose in 18 F-FDG and 18 F-FDOPA PET/CT examinations
    Kaushik, Aruna
    Jaimini, Abhinav
    Tripathi, Madhavi
    D'Souza, Maria
    Sharma, Rajnish
    Mishra, Anil K.
    Mondal, Anupam
    Dwarakanath, Bilikere S.
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2013, 9 (03) : 477 - 483
  • [17] Interim (18)F-FDG PET prognostic value in Hodgkin lymphoma patients
    Kirienko, Margarita
    Guerra, Luca
    Bolis, Silvia
    Sassone, Marianna
    De Ponti, Elena
    Messa, Cristina
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [18] Comparison of 18F-FDG-PET/CT and 18F-FDG-PET/MR imaging in oncology: a systematic review
    Amit Singnurkar
    Raymond Poon
    Ur Metser
    Annals of Nuclear Medicine, 2017, 31 : 366 - 378
  • [19] Robustness of radiomic features in [18F]-FDG PET/CT and [18F]-FDG PET/MR
    Vuong, D.
    Bogowicz, M.
    Huellner, M.
    Veit-Haibach, P.
    Andratschke, N.
    Unkelbach, J.
    Guckenberger, M.
    Tanadini-Lang, S.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : S41 - S41
  • [20] Effectiveness of 18 F-FDG PET/CT in detecting cranial nerve pathology
    Raslan, Osama
    Allam, Talha
    Kujawa, Kyle
    Brock, Kyle
    Muzaffar, Razi
    Shetty, Vilaas
    Varvares, Mark
    Osman, Medhat
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55